Antigens/ELISA tests used | |||||
---|---|---|---|---|---|
Parasitic disease | |||||
AgEm | AgB | AgHF | NovaLisaTM | ||
Alveolar echinococcosis (n = 10) | 9 | n.c. | n.c. | n.c. | 8 |
Cystic echinococcosis (n = 17) | n.c. | 13 | 17 | 15 | 13 |
Antigens/ELISA tests used | |||||
---|---|---|---|---|---|
Parasitic/other infections | |||||
AgEm | AgB | AgHF | NovaLisaTM | ||
Alveolar echinococcosis (n = 10) | n.c. | 9 | 7 | 10 | n.c. |
Cystic echinococcosis (n = 17) | 0 | n.c. | n.c. | n.c. | n.c. |
Ascariasis (n = 8) | 0 | 0 | 0 | 1 | 0 |
Trichuriasis (n = 4) | 0 | 0 | 0 | 0 | 0 |
Trichinellosis (n = 8) | 0 | 0 | 0 | 0 | 1 |
Toxocariasis (n = 9) | 0 | 0 | 0 | 1 | 0 |
Toxoplasmosis (n = 8) | 0 | 1 | 1 | 0 | 0 |
Strongyloidiasis (n = 6) | 0 | 0 | 2 | 1 | 0 |
Dirofilariasis (n = 1) | 0 | 0 | 0 | 0 | 0 |
Ricketsiosis (n = 1) | 0 | 0 | 0 | 0 | 0 |
Clinically healthy persons (n = 25) | 0 | 2 | 1 | 2 | 2 |
Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |||
---|---|---|---|---|---|---|
Antigen/test | Parasitic disease | (95% CI) | (95% CI) | (95% CI) | (95% CI) | YI |
AgEm | 90.0 | 100 | 100 | 98.9 | 0.90 | |
(55.5–99.8) | (96.6–100) | n.c. | (93.1–99.8) | |||
76.5 | 85.0 | 52.0 | 94.4 | |||
AgB | (50.1–93.2) | (75.4–91.4) | (37.7–66.0) | (87.8–97.6) | 0.61 | |
100 | 86.3 | 60.7 | 100 | |||
AgHF | (83.8–100) | (76.7–92.9) | (47.2–72.8) | n.c. | 0.86 | |
88.2 | 83.8 | 53.6 | 97.1 | |||
(63.6–98.5) | (73.8–91.1) | (40.5–66.2) | (90.1–99.2) | 0.72 | ||
77.8 | 95.7 | 87.5 | 91.8 | |||
NovaLisaTM | (57.7–91.4) | (87.8–99.1) | (69.4–95.6) | (84.6–95.8) | 0.74 |